Etoposide and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etoposide (etoposide) and Mesalamine (mesalamine). Common drug interactions include drug ineffective among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Etoposide and Mesalamine. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.

On Jul, 13, 2026

29 people who take Etoposide and Mesalamine together, and have interactions are studied.

Etoposide and Mesalamine drug interactions.

What are the common drug interactions of Etoposide and Mesalamine, by gender? *:

female:

Drug ineffective
Febrile neutropenia (fever with reduced white blood cells)
Escherichia infection (bacterial infection by escherichia coli)
Haematoma (collection of blood outside the blood vessels)
Hepatotoxicity (chemical-driven liver damage)
Leukopenia (less number of white blood cells in blood)
Sepsis (a severe blood infection that can lead to organ failure and death)
Thrombocytopenia (decrease of platelets in blood)
Angiocentric lymphoma (extra nodal natural killer cell cancer)
Bone pain

male:

Drug ineffective
Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
Cardiac infection (an infection of the heart)
Central nervous system infection (infection of brain or spinal cord)
Cerebral haemorrhage (bleeding within the brain)
Cholecystitis (infection of gallbladder)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Cytomegalovirus colitis (an inflammation of the colon from virus)
Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Death

What are the common drug interactions of Etoposide and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Drug ineffective
Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
Cytomegalovirus infection
Pancreatitis (inflammation of pancreas)
Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)

10-19:

Escherichia sepsis (bacterial infection by escherichia coli)
Atypical mycobacterial infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis)
Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Disease progression
Drug ineffective
Febrile neutropenia (fever with reduced white blood cells)
Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
Klebsiella bacteraemia (klebsiella bacteria in blood after infection to lungs)
Mycobacterium abscessus infection (rapid growing bacterial infection)

20-29:

Drug ineffective
Hepatotoxicity (chemical-driven liver damage)
Bacteraemia (presence of bacteria in the blood)
Mycobacterial infection
Nausea (feeling of having an urge to vomit)
Skin infection
Vomiting

30-39:

Cytomegalovirus colitis (an inflammation of the colon from virus)
Death
Drug ineffective
Escherichia sepsis (bacterial infection by escherichia coli)
Hodgkin's disease nodular sclerosis stage unspecified (cancer originating from white blood cells -unspecified)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Metastases to bone (cancer spreads to bone)
Multi-organ failure (multisystem organ failure)
Septic shock (shock due to blood infection)

40-49:

n/a

50-59:

Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
Systemic candida (whole body fungal infection)
Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
Dehydration (dryness resulting from the removal of water)
Febrile neutropenia (fever with reduced white blood cells)
Pericardial effusion malignant (cancerous fluid around the heart)
Pericarditis (inflammation of the pericardium)
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)

60+:

Bone pain
Cardiac infection (an infection of the heart)
Gastrointestinal infection (infection of stomach and intestine)
Hepatic failure (liver failure)
Hepatic haemorrhage (bleeding inside liver)
Hepatic infection
Hypokalaemia (low potassium)
Hypotension (abnormally low blood pressure)
Immunosuppression
Interstitial lung disease

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 12 people, 41.38%
Bone Marrow Conditioning Regimen: 8 people, 27.59%
Aplastic Anemia: 5 people, 17.24%
Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 2 people, 6.90%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 2 people, 6.90%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 6.90%
Lung Cancer - Small Cell (lung cancer): 2 people, 6.90%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously